Effects Of GW572016 In Combination With Docetaxel (TAXOTERE)

• Status: Completed
• Trial end date: 2006-01-21
• Target enrollment: 0
• Participant gender: All

Summary

This is a safety and tolerability study of GW572016 given with docetaxel (TAXOTERE).

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Docetaxel; Lapatinib

Criteria

Inclusion Criteria:

• Advanced solid tumors.

• Able to swallow oral medication.